(Q60171856)

https://api.crossref.org/works/10.1039%2FCS9901900271

A new route to “bifunctional” chelating agents: Conversion of amino acids to analogs of ethylenedinitrilotetraacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Antibody labelling with functionalised cyclam macrocycles

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Cavitands: organic hosts with enforced cavities

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Positron emission tomography: human brain function and biochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Bismuth-212-labeled anti-Tac monoclonal antibody: alpha-particle-emitting radionuclides as modalities for radioimmunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Synthesis and characterization of stable rhenium(V) dioxo complexes with acyclic tetraamine ligands, [LReO2]+

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Synthesis of 1,10-dithia-4,7,13,16-tetra-azacyclo-octadecane, 1-aza-4,7-dithiacyclononane, and N,N′-1,2-bis(1-aza-4,7-dithia-cyclononyl)ethane. Structural and solution studies of their silver complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Replacing the complementarity-determining regions in a human antibody with those from a mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Assembly of a functional immunoglobulin Fv fragment in Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Expression of an antibody Fv fragment in myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Conjugation of antibodies with bifunctional chelating agents: isothiocyanate and bromoacetamide reagents, methods of analysis, and subsequent addition of metal ions

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates: synthesis, antibody linkage, and complexation behaviour

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Site-specific covalent modification of monoclonal antibodies: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Towards tumour targeting with copper-radiolabelled macrocycle–antibody conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

1,4,7-Triazacyclononane-N,N',N''-triacetate (TCTA), a new hexadentate ligand for divalent and trivalent metal ions. Crystal structures of [CrIII(TCTA)], [FeIII(TCTA)], and Na[CuII(TCTA)].bul.2NaBr.bul.8H2O

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Selective N,N-functionalisation of cyclam: crystal structure of the Cu2+ complex of 1,4,8,11-tetra-azacyclotetradecane-1,8-diacetic acid and the tricyclic lactam 15,18-dioxo-1,5,8,12-tetra-azatricyclo[10.2.2.25.8]tetradecane

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Copper chelates as probes of biological systems: stable copper complexes with a macrocyclic bifunctional chelating agent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Labeling of antibodies with 64Cu using a conjugate containing a macrocyclic amine chelating agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Labeling antibodies with copper radionuclides using N-4-nitrobenzyl-5-(4-carboxyphenyl)-10,15,20-tris(4-sulfophenyl) porphine

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

A spectrum of monoclonal antibodies reactive with human mammary tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Towards tumour imaging with indium-111 labelled macrocycle–antibody conjugates

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Stability, 71Ga NMR, and crystal structure of a neutral gallium(III) complex of 1,4,7-triazacyclononanetriacetate: a potential radiopharmaceutical?

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Crystal and molecular structure of a seven-coordinate chloroindium(III) complex of 1,4,7-triazacyclononanetriacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Synthesis of C- and N-functionalised derivatives of 1,4,7-triazacyclononane-1,4,7-triyltriacetic acid (NOTA), 1,4,7,10-tetra-azacyclododecane-1,4,7,10-tetrayltetra-acetic acid (DOTA), and diethylenenetriaminepenta-acetic acid (DTPA): bifunctional com

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Synthesis of a kinetically stable yttrium-90 labelled macrocycle–antibody conjugate

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

Metal complexes of 1-oxa-4,7,10-triazacyclododecane-N,N',N''-triacetic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271

The peptide way to macrocyclic bifunctional chelating agents: synthesis of 2-(p-nitrobenzyl)-1,4,7,10-tetraazacyclododecane-N,N',N",N'''-tetraacetic acid and study of its yttrium(III) complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1039%2FCS9901900271